山东药玻(600529.SH)上半年净利润为3.71亿元，同比下降21.9%

Group 1 - The core viewpoint of the article is that Shandong Pharmaceutical Glass (600529.SH) reported a decline in both revenue and net profit for the first half of 2025 compared to the previous year [1] Group 2 - The company's operating revenue for the first half of 2025 was 2.37 billion yuan, representing a year-on-year decrease of 8.2% [1] - The net profit attributable to the parent company was 371 million yuan, showing a year-on-year decline of 21.9% [1] - The net profit after deducting non-recurring gains and losses was 355 million yuan, which is a year-on-year decrease of 22.0% [1]